The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Immix Biopharma Inc’s current trading price is -10.94% away from its 52-week high, while its distance from the 52-week low is 126.19%. The stock’s price range for this period has been between $1.26 and $3.20 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.72 million for the day, a number notably higher than the average daily volume of 0.27 million over the last three months.
The stock price for Immix Biopharma Inc (IMMX) currently stands at $2.85. The stock experienced a substantial increase in the last session, hitting $7.0 after starting at $2.85. The stock’s lowest price was $7.0 before closing at $2.54.
Immix Biopharma Inc’s market performance has been stable in recent times.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Immix Biopharma Inc (IMMX) has experienced a quarterly rise of 40.39% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 79.45M and boasts a workforce of 21 employees.
Immix Biopharma Inc: What Analysts Are Saying
As of right now, 0 analyst is rating Immix Biopharma Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.16, with a change in price of +1.22. Similarly, Immix Biopharma Inc recorded 200,304 in trading volume during the last 100 days, posting a change of +74.85%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for IMMX stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.10.
IMMX Stock Stochastic Average
Immix Biopharma Inc’s raw stochastic average for the past 50 days is presently 73.68%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 50.00%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 27.46% and 30.61%, respectively.
IMMX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 37.02%. However, over the past six months, we’ve seen a weaker performance of 46.15%. The price of IMMX fallen by 8.78% over the last 30 days. And in the last five days, it has surged by 5.56%.
